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Background: Prognostic significance of growth differentiation factor 15 (GDF15) and its short term change, in heart failure with preserved (HFPEF) 
vs reduced ejection fraction (HFREF) is not fully understood.
methods: Circulating GDF15 and N Terminal pro B type Natriuretic Peptide (NTproBNP) were measured at baseline in patients with HFREF 
(EF<50%; n=246; age 60±11), HFPEF (EF≥50%; n=47; age 68±11) and controls without HF (n=238; age 59±10). In a subset of 191 patients (164 
HFREF, 27 HFPEF), GDF15 was re-measured at 6 weeks. Subjects were followed up for death or HF hospitalization.
results: At baseline, median GDF15 was similarly elevated in HFPEF (2978ng/L) and HFREF (2685ng/L) compared to controls (609ng/L)
(both P<0.001 vs controls; HFPEF vs HFREF P=1.0). Higher GDF15 correlated with higher age, lower glomerular filtration rate, diabetes and higher 
NTproBNP (all P<0.03). Over a 1 year period, there were 108 events (90 HFREF, 16 HFPEF, 2 controls). Higher GDF15 was associated with higher 
event rate (P<0.001) (Figure 1), adjusting for age, sex, cardiovascular risk factors and NTproBNP (adjusted HR 2.46 per 1Ln U; P=0.001). The 
risk was similar for HFPEF and HFREF (interaction P=0.33). In the subset of 191 patients, the mean % change in GDF15 over 6 weeks was small 
(-9±43%) and did not independently relate to events.
conclusion: GDF15 is elevated in HFREF and HFPEF at presentation, remains relatively stable over 6 weeks, and provides prognostic information at 
1 year independent of clinical risk factors and NTproBNP.
 
